558 related articles for article (PubMed ID: 16793897)
21. ATP-sensitive potassium channels in cultured arterial segments.
Kleppisch T; Winter B; Nelson MT
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2462-8. PubMed ID: 8997306
[TBL] [Abstract][Full Text] [Related]
22. Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway.
Carroll MA; Doumad AB; Li J; Cheng MK; Falck JR; McGiff JC
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F155-61. PubMed ID: 16478979
[TBL] [Abstract][Full Text] [Related]
23. Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid.
Eckman DM; Hopkins N; McBride C; Keef KD
Br J Pharmacol; 1998 May; 124(1):181-9. PubMed ID: 9630358
[TBL] [Abstract][Full Text] [Related]
24. Epoxyeicosatrienoic acids and endothelium-dependent responses.
Campbell WB; Fleming I
Pflugers Arch; 2010 May; 459(6):881-95. PubMed ID: 20224870
[TBL] [Abstract][Full Text] [Related]
25. EET homologs potently dilate coronary microvessels and activate BK(Ca) channels.
Zhang Y; Oltman CL; Lu T; Lee HC; Dellsperger KC; VanRollins M
Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2430-40. PubMed ID: 11356595
[TBL] [Abstract][Full Text] [Related]
26. The nitric oxide- and prostaglandin-independent component of the renal vasodilator effect of thimerosal is mediated by epoxyeicosatrienoic acids.
Chen YJ; Jiang H; Quilley J
J Pharmacol Exp Ther; 2003 Mar; 304(3):1292-8. PubMed ID: 12604709
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of epoxyeicosatrienoic acids on volume-activated chloride channels in rat mesenteric arterial smooth muscle.
Yang C; Kwan YW; Seto SW; Leung GP
Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):62-7. PubMed ID: 18812234
[TBL] [Abstract][Full Text] [Related]
28. Epoxyeicosatrienoic acid activates BK channels in the cortical collecting duct.
Sun P; Liu W; Lin DH; Yue P; Kemp R; Satlin LM; Wang WH
J Am Soc Nephrol; 2009 Mar; 20(3):513-23. PubMed ID: 19073823
[TBL] [Abstract][Full Text] [Related]
29. Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein.
Li PL; Campbell WB
Circ Res; 1997 Jun; 80(6):877-84. PubMed ID: 9168791
[TBL] [Abstract][Full Text] [Related]
30. Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways.
Wang Z; Wei Y; Falck JR; Atcha KR; Wang WH
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1441-7. PubMed ID: 18417544
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle.
Gebremedhin D; Ma YH; Falck JR; Roman RJ; VanRollins M; Harder DR
Am J Physiol; 1992 Aug; 263(2 Pt 2):H519-25. PubMed ID: 1510149
[TBL] [Abstract][Full Text] [Related]
32. A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels.
Liu Y; Zhang J; Yu L; Cao F; Rao J; Li J; Jiang C; Falck JR; Jacobs ER; Zhu D
Pulm Pharmacol Ther; 2012 Feb; 25(1):69-76. PubMed ID: 22155000
[TBL] [Abstract][Full Text] [Related]
33. Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways.
Wei Y; Lin DH; Kemp R; Yaddanapudi GS; Nasjletti A; Falck JR; Wang WH
J Gen Physiol; 2004 Dec; 124(6):719-27. PubMed ID: 15545402
[TBL] [Abstract][Full Text] [Related]
34. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
Wang B; Zeng H; Wen Z; Chen C; Wang DW
Aging Cell; 2016 Oct; 15(5):940-52. PubMed ID: 27416746
[TBL] [Abstract][Full Text] [Related]
35. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
[TBL] [Abstract][Full Text] [Related]
36. Protective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channels.
Bodiga S; Zhang R; Jacobs DE; Larsen BT; Tampo A; Manthati VL; Kwok WM; Zeldin DC; Falck JR; Gutterman DD; Jacobs ER; Medhora MM
J Mol Cell Cardiol; 2009 Jun; 46(6):978-88. PubMed ID: 19336274
[TBL] [Abstract][Full Text] [Related]
37. Role of PI3Kα and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection.
Batchu SN; Chaudhary KR; El-Sikhry H; Yang W; Light PE; Oudit GY; Seubert JM
J Mol Cell Cardiol; 2012 Jul; 53(1):43-52. PubMed ID: 22561102
[TBL] [Abstract][Full Text] [Related]
38. Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response.
Samokhvalov V; Alsaleh N; El-Sikhry HE; Jamieson KL; Chen CB; Lopaschuk DG; Carter C; Light PE; Manne R; Falck JR; Seubert JM
Cell Death Dis; 2013 Oct; 4(10):e885. PubMed ID: 24157879
[TBL] [Abstract][Full Text] [Related]
39. Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity.
Zou AP; Fleming JT; Falck JR; Jacobs ER; Gebremedhin D; Harder DR; Roman RJ
Am J Physiol; 1996 May; 270(5 Pt 2):F822-32. PubMed ID: 8928844
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.
Gross GJ; Hsu A; Falck JR; Nithipatikom K
J Mol Cell Cardiol; 2007 Mar; 42(3):687-91. PubMed ID: 17217955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
